These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26566491)

  • 1. The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development.
    Kim YM; Kahn M
    Res Rep Biochem; 2014; 4():1-12. PubMed ID: 26566491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt Signaling in Stem Cells and Tumor Stem Cells.
    Kahn M
    Semin Reprod Med; 2015 Sep; 33(5):317-25. PubMed ID: 26251120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wnt signaling pathway in cancer.
    Duchartre Y; Kim YM; Kahn M
    Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators.
    Kahn M
    Prog Mol Biol Transl Sci; 2018 Jan; 153():209-244. PubMed ID: 29389517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safely targeting cancer stem cells via selective catenin coactivator antagonism.
    Lenz HJ; Kahn M
    Cancer Sci; 2014 Sep; 105(9):1087-92. PubMed ID: 24975284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.
    Bhuvanalakshmi G; Basappa ; Rangappa KS; Dharmarajan A; Sethi G; Kumar AP; Warrier S
    Front Pharmacol; 2017; 8():124. PubMed ID: 28373842
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting Wnt signaling: can we safely eradicate cancer stem cells?
    Takahashi-Yanaga F; Kahn M
    Clin Cancer Res; 2010 Jun; 16(12):3153-62. PubMed ID: 20530697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.
    Cai C; Zhu X
    Mol Med Rep; 2012 May; 5(5):1191-6. PubMed ID: 22367735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.
    Jang GB; Kim JY; Cho SD; Park KS; Jung JY; Lee HY; Hong IS; Nam JS
    Sci Rep; 2015 Jul; 5():12465. PubMed ID: 26202299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.
    Kim JH; Park SY; Jun Y; Kim JY; Nam JS
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy.
    Li J; Ji L; Chen J; Zhang W; Ye Z
    Biomed Res Int; 2015; 2015():964842. PubMed ID: 26078973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma.
    Pandit H; Li Y; Li X; Zhang W; Li S; Martin RCG
    BMC Cancer; 2018 Aug; 18(1):783. PubMed ID: 30075764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.
    Benoit YD; Guezguez B; Boyd AL; Bhatia M
    Clin Cancer Res; 2014 Nov; 20(21):5372-8. PubMed ID: 25006223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.